(Q39448143)
Statements
1 reference
Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group (English)
1 reference
Teall J
1 reference
Tuchman M
1 reference
Cutler N
1 reference
Gross M
1 reference
Willoughby E
1 reference
Smith B
1 reference
Jiang K
1 reference
Reines S
1 reference
Block G
1 reference
1 April 1998
1 reference
Identifiers
1 reference